Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesManagement of Hypercholesterolemia
Geriatrics & Aging, 11/10/09
Aronow WS – The updated National Cholesterol Education Program (NCEP) III guidelines state that in very–high–risk patients, a serum low–density lipoprotein (LDL) cholesterol level of <1.81 mmol/L (<70 mg/dL) correct is a reasonable clinical strategy, regardless of age. When a high–risk person has hypertriglyceridemia or low serum high–density lipoprotein cholesterol, consideration can be given to combining a fibrate or nicotinic acid with an LDL cholesterol–lowering drug. For moderately high–risk persons, the serum LDL cholesterol should be reduced to <2.59 mmol/L 2.59 (<100 mg/dL). When LDL cholesterol–lowering drug therapy is used to treat high–risk persons or moderately high–risk persons, the serum LDL cholesterol should be reduced by at least 30–40%. High–risk older persons should be treated with lipid–lowering drug therapy according to NCEP III updated guidelines to reduce cardiovascular morbidity and mortality. The LDL cholesterol should be reduced to <4.14 mmol/L (<160 mg/dL)correct in persons at low risk for cardiovascular disease.
Related Articles
Self-Reported Adherence to Nonpharmacological Treatment and Association with Mortality over 6 Years: Population-Based Study in Older Persons with Hypercholesterolemia
Journal of the American Geriatrics Society, 10/28/09
Relevance Score: 88%
U.S. Food and Drug Administration approves CRESTOR for use in pediatric patients with heterozygous familial hypercholesterolemia
AstraZeneca, 10/19/09
Relevance Score: 84%
Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)
Atherosclerosis, 10/14/09
Relevance Score: 84%
Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia
Metabolism-Clinical and Experimental, 10/13/09
Relevance Score: 84%
The Effect of Hypercholesterolemia on Rotator Cuff Disease
Clinical Orthopedics and Related Research, 11/13/09
Relevance Score: 83%
Today in Atherosclerosis/Lipids...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-Density Lipoprotein Cholesterol Reduction and Goal Achievement With Ezetimibe/Simvastatin Versus Atorvastatin or Rosuvastatin in Patients With Diabetes, Metabolic Syndrome, or Neither Disease, Stratified By National Cholesterol Education Program Risk Category
Metabolic Syndrome and Related Disorders, 11/25/09
Carotid Intima-Media Thickness: Knowledge and Application to Everyday Practice
Postgraduate Medicine, 11/25/09
Different impacts of saturated and unsaturated free fatty acids on COX-2 expression in C2C12 myotubes
Endocrinology and Metabolism, 11/25/09
Sponsor
Article Search
Sponsor